Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 23 2025
0mins
Source: Newsfilter
Quanterix Corporation's Merger Concerns: Kent Lake PR LLC, a significant shareholder of Quanterix Corporation, has expressed strong opposition to the company's amended merger agreement with Akoya Biosciences, highlighting that the terms are unfavorable and risk further value destruction for shareholders.
Call for Strategic Alternatives: Kent Lake urges the Quanterix Board to reconsider its pursuit of Akoya in light of a superior third-party cash offer, suggesting that the board should explore other strategic options instead of compromising the company's financial stability.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
